Correlation Between Actinogen Medical and FSA Group

Can any of the company-specific risk be diversified away by investing in both Actinogen Medical and FSA Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinogen Medical and FSA Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Actinogen Medical and FSA Group, you can compare the effects of market volatilities on Actinogen Medical and FSA Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinogen Medical with a short position of FSA Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinogen Medical and FSA Group.

Diversification Opportunities for Actinogen Medical and FSA Group

0.64

Correlation Coefficient

Actinogen Medical  FSA Group

Poor diversification

The 3 months correlation between Actinogen and FSA is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Actinogen Medical and FSA Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FSA Group and Actinogen Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinogen Medical are associated (or correlated) with FSA Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FSA Group has no effect on the direction of Actinogen Medical i.e., Actinogen Medical and FSA Group go up and down completely randomly.

Pair Corralation between Actinogen Medical and FSA Group

Assuming the 90 days trading horizon Actinogen Medical is expected to generate 2.7 times more return on investment than FSA Group. However, Actinogen Medical is 2.7 times more volatile than FSA Group. It trades about 0.13 of its potential returns per unit of risk. FSA Group is currently generating about 0.07 per unit of risk. If you would invest  2.40  in Actinogen Medical on December 27, 2024 and sell it today you would earn a total of  1.00  from holding Actinogen Medical or generate 41.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Actinogen Medical  vs.  FSA Group

Actinogen Medical

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Actinogen Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Actinogen Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

FSA Group

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in FSA Group are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, FSA Group may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Actinogen Medical and FSA Group

The main advantage of trading using opposite Actinogen Medical and FSA Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinogen Medical position performs unexpectedly, FSA Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FSA Group will offset losses from the drop in FSA Group's long position.

The idea behind Actinogen Medical and FSA Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.